OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody status following booster vaccination against SARS‐CoV ‐2 virus in patients with haematologic malignancies
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 5, pp. 568-572
Open Access | Times Cited: 7
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 5, pp. 568-572
Open Access | Times Cited: 7
Showing 7 citing articles:
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
Tzong‐Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 403-413
Open Access | Times Cited: 2
Tzong‐Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 403-413
Open Access | Times Cited: 2
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study
Stella Rosa Maria Wirth, Klaus Podar, Martin Pecherstorfer, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 524-524
Open Access | Times Cited: 3
Stella Rosa Maria Wirth, Klaus Podar, Martin Pecherstorfer, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 524-524
Open Access | Times Cited: 3
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
Jean‐François Rossi, Emmanuel Bonnet, Christel Castelli, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 493-493
Open Access | Times Cited: 1
Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease
Hiroki Kobayashi, Tomoki Ouchi, Wataru Kitamura, et al.
Journal of Clinical and Experimental Hematopathology (2023) Vol. 63, Iss. 4, pp. 246-250
Open Access | Times Cited: 1
Hiroki Kobayashi, Tomoki Ouchi, Wataru Kitamura, et al.
Journal of Clinical and Experimental Hematopathology (2023) Vol. 63, Iss. 4, pp. 246-250
Open Access | Times Cited: 1
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies
Chien-Tzu Huang, Ching-Ping Lee, Tzu‐Yin Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5647-5647
Open Access
Chien-Tzu Huang, Ching-Ping Lee, Tzu‐Yin Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5647-5647
Open Access
Prevalence and clinical outcome of Omicron breakthrough infection in patients with hematologic disease: a prospective observational cohort study
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
